Pharmacy Benefit Manager Accountability Study Act of 2021
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Pharmacy Benefit Manager Accountability Study Act of 2021
This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 298: Pharmacy Benefit Manager Accountability Study Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-298/
"S. 298: Pharmacy Benefit Manager Accountability Study Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-298/.
S. 298, 117th Cong. (2026), https://openamerica.io/bill/117-S-298/.
[S. 298: Pharmacy Benefit Manager Accountability Study Act of 2021](https://openamerica.io/bill/117-S-298/)